Oregon Public Employees Retirement Fund decreased its stake in Maximus, Inc. (NYSE:MMS – Get Rating) by 1.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,683 shares of the health services provider’s stock after selling 174 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Maximus were worth $1,023,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Avantax Advisory Services Inc. boosted its position in Maximus by 5.2% during the second quarter. Avantax Advisory Services Inc. now owns 8,418 shares of the health services provider’s stock valued at $526,000 after purchasing an additional 414 shares during the last quarter. Verition Fund Management LLC grew its stake in shares of Maximus by 128.3% in the 2nd quarter. Verition Fund Management LLC now owns 138,803 shares of the health services provider’s stock valued at $8,677,000 after buying an additional 78,012 shares in the last quarter. HGK Asset Management Inc. increased its holdings in Maximus by 10.6% in the second quarter. HGK Asset Management Inc. now owns 10,500 shares of the health services provider’s stock worth $656,000 after buying an additional 1,003 shares during the last quarter. Zeke Capital Advisors LLC raised its position in Maximus by 48.2% during the second quarter. Zeke Capital Advisors LLC now owns 4,106 shares of the health services provider’s stock valued at $257,000 after acquiring an additional 1,336 shares in the last quarter. Finally, Nordea Investment Management AB lifted its stake in Maximus by 169.4% in the second quarter. Nordea Investment Management AB now owns 235,241 shares of the health services provider’s stock valued at $14,458,000 after acquiring an additional 147,930 shares during the last quarter. 97.41% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on MMS. StockNews.com started coverage on shares of Maximus in a report on Wednesday, October 12th. They set a “hold” rating on the stock. TheStreet upgraded Maximus from a “c+” rating to a “b-” rating in a report on Thursday, December 8th.
Insider Transactions at Maximus
Maximus Stock Up 0.3 %
Shares of Maximus stock opened at $72.62 on Tuesday. Maximus, Inc. has a 12-month low of $54.46 and a 12-month high of $79.78. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.83. The stock has a 50 day moving average price of $71.13 and a two-hundred day moving average price of $64.62. The stock has a market capitalization of $4.41 billion, a P/E ratio of 22.07 and a beta of 0.70.
Maximus (NYSE:MMS – Get Rating) last announced its earnings results on Monday, November 21st. The health services provider reported $1.40 EPS for the quarter, topping the consensus estimate of $1.02 by $0.38. The firm had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.09 billion. Maximus had a net margin of 4.40% and a return on equity of 17.59%. Equities analysts expect that Maximus, Inc. will post 3.87 earnings per share for the current year.
Maximus Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 28th. Investors of record on Wednesday, February 15th will be paid a dividend of $0.28 per share. The ex-dividend date of this dividend is Tuesday, February 14th. This represents a $1.12 annualized dividend and a yield of 1.54%. Maximus’s payout ratio is 34.04%.
Maximus Company Profile
MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.
- Get a free copy of the StockNews.com research report on Maximus (MMS)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.